477 related articles for article (PubMed ID: 31494395)
1. The impact of age on the outcome of patients treated with radiotherapy for mucoepidermoid carcinoma (MEC) of the salivary glands in the head and neck: A 15-year single-center experience.
Akbaba S; Heusel A; Mock A; Held T; Lang K; Hoerner-Rieber J; Forster T; Katayama S; Kargus S; Rieken S; Plinkert P; Herfarth K; Debus J; Adeberg S
Oral Oncol; 2019 Oct; 97():115-123. PubMed ID: 31494395
[TBL] [Abstract][Full Text] [Related]
2. Results of a combination treatment with intensity modulated radiotherapy and active raster-scanning carbon ion boost for adenoid cystic carcinoma of the minor salivary glands of the nasopharynx.
Akbaba S; Ahmed D; Lang K; Held T; Mattke M; Hoerner-Rieber J; Herfarth K; Rieken S; Plinkert P; Debus J; Adeberg S
Oral Oncol; 2019 Apr; 91():39-46. PubMed ID: 30926061
[TBL] [Abstract][Full Text] [Related]
3. Treatment Outcome of a Combined Dose-Escalated Treatment Regime With Helical TomoTherapy® and Active Raster-Scanning Carbon Ion Boost for Adenocarcinomas of the Head and Neck.
Akbaba S; Mock A; Hoerner-Rieber J; Held T; Katayama S; Forster T; Freudlsperger C; Rieken S; Herfarth K; Plinkert P; Debus J; Adeberg S
Front Oncol; 2019; 9():755. PubMed ID: 31475108
[No Abstract] [Full Text] [Related]
4. Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival.
Jensen AD; Nikoghosyan AV; Poulakis M; Höss A; Haberer T; Jäkel O; Münter MW; Schulz-Ertner D; Huber PE; Debus J
Cancer; 2015 Sep; 121(17):3001-9. PubMed ID: 26043145
[TBL] [Abstract][Full Text] [Related]
5. Hypopharyngeal squamous cell carcinoma: Three-dimensional or Intensity-modulated radiotherapy? A single institution's experience.
Katsoulakis E; Riaz N; Hu M; Morris L; Sherman E; McBride S; Lee N
Laryngoscope; 2016 Mar; 126(3):620-6. PubMed ID: 26597398
[TBL] [Abstract][Full Text] [Related]
6. Long term results of postoperative Intensity-Modulated Radiation Therapy (IMRT) in the treatment of Squamous Cell Carcinoma (SCC) located in the oropharynx or oral cavity.
Hoffmann M; Saleh-Ebrahimi L; Zwicker F; Haering P; Schwahofer A; Debus J; Huber PE; Roeder F
Radiat Oncol; 2015 Dec; 10():251. PubMed ID: 26637471
[TBL] [Abstract][Full Text] [Related]
7. Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?
Jensen AD; Poulakis M; Vanoni V; Uhl M; Chaudhri N; Federspil PA; Freier K; Krauss J; Debus J
Radiat Oncol; 2016 Jul; 11(1):90. PubMed ID: 27386864
[TBL] [Abstract][Full Text] [Related]
8. Large German Multicenter Experience on the Treatment Outcome of 207 Patients With Adenoid Cystic Carcinoma of the Major Salivary Glands.
Akbaba S; Bostel T; Lang K; Bahadir S; Lipman D; Schmidberger H; Matthias C; Rotter N; Knopf A; Freudlsperger C; Plinkert P; Debus J; Adeberg S
Front Oncol; 2020; 10():593379. PubMed ID: 33262950
[TBL] [Abstract][Full Text] [Related]
9. The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly.
Haehl E; Rühle A; Klink R; Kalckreuth T; Sprave T; Gkika E; Zamboglou C; Meiß F; Grosu AL; Nicolay NH
Radiat Oncol; 2021 Jun; 16(1):105. PubMed ID: 34118984
[TBL] [Abstract][Full Text] [Related]
10. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.
Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH
Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456
[TBL] [Abstract][Full Text] [Related]
11. Intensity modulated radiation therapy (IMRT) for sinonasal tumors: a single center long-term clinical analysis.
Askoxylakis V; Hegenbarth P; Timke C; Saleh-Ebrahimi L; Debus J; Röder F; Huber PE
Radiat Oncol; 2016 Feb; 11():17. PubMed ID: 26847089
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled study comparing simultaneous modulated accelerated radiotherapy versus simultaneous integrated boost intensity modulated radiotherapy in the treatment of locally advanced head and neck cancer.
Tandon S; Gairola M; Ahlawat P; Rawat S; Aggarwal A; Sharma K; Tiwari S; Karimi AM; Muttagi V; Sachdeva N; Bhushan M
J Egypt Natl Canc Inst; 2018 Sep; 30(3):107-115. PubMed ID: 29960876
[TBL] [Abstract][Full Text] [Related]
13. Intensity-Modulated Proton and Carbon-Ion Radiation Therapy in the Management of Head and Neck Sarcomas.
Yang J; Gao J; Qiu X; Hu J; Hu W; Wu X; Zhang C; Ji T; Kong L; Lu JJ
Cancer Med; 2019 Aug; 8(10):4574-4586. PubMed ID: 31231939
[TBL] [Abstract][Full Text] [Related]
14. A comparative analysis between sequential boost and integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer.
Vlacich G; Stavas MJ; Pendyala P; Chen SC; Shyr Y; Cmelak AJ
Radiat Oncol; 2017 Jan; 12(1):13. PubMed ID: 28086954
[TBL] [Abstract][Full Text] [Related]
15. Intensity Modulated Radiotherapy (IMRT) With Carbon Ion Boost in the Multimodal Treatment of Salivary Duct Carcinoma.
Adeberg S; Windisch P; Ehret F; Baur M; Akbaba S; Held T; Bernhardt D; Haefner MF; Krauss J; Kargus S; Freudlsperger C; Plinkert P; Flechtenmacher C; Herfarth K; Debus J; Rieken S
Front Oncol; 2019; 9():1420. PubMed ID: 31921675
[No Abstract] [Full Text] [Related]
16. Long-term outcomes and quality of life of 186 patients with primary parotid carcinoma treated with surgery and radiotherapy at the Daniel den Hoed Cancer Center.
Al-Mamgani A; van Rooij P; Verduijn GM; Meeuwis CA; Levendag PC
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):189-95. PubMed ID: 22330990
[TBL] [Abstract][Full Text] [Related]
17. Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy.
Schoenfeld JD; Sher DJ; Norris CM; Haddad RI; Posner MR; Balboni TA; Tishler RB
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):308-14. PubMed ID: 21075557
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity.
Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
Radiat Oncol; 2017 Aug; 12(1):131. PubMed ID: 28810885
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
[TBL] [Abstract][Full Text] [Related]
20. Bimodal Radiotherapy with Active Raster-Scanning Carbon Ion Radiotherapy and Intensity-Modulated Radiotherapy in High-Risk Nasopharyngeal Carcinoma Results in Excellent Local Control.
Akbaba S; Held T; Lang K; Forster T; Federspil P; Herfarth K; Häfner M; Plinkert P; Rieken S; Debus J; Adeberg S
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30884910
[No Abstract] [Full Text] [Related]
[Next] [New Search]
